IF EVER there was a telling illustration of the power of the immune system, it came in 2006. Six men in a trial of an experimental drug made by the company TeGenero became critically ill after suffering a catastrophic over-stimulation of the immune system. The T-cells, the "master regulators" of the body's immune system, had turned against it.
Now it seems we may have a "shadow" immune system ruled by B cells, usually portrayed as foot soldiers that do the bidding of T-cells. Tinkering with this aspect of the immune system (page 6) could yield new ways of treating autoimmune diseases and cancer. But, exciting as this is, let's not forget the TeGenero story. We must understand shadow immunity much better before we can even think of tweaking it in people.
- Like what you've just read?
- Don't miss out on the latest content from New Scientist.
- Get New Scientist magazine delivered to your door, plus unlimited access to the entire content of New Scientist online.
- Subscribe now and save
If you would like to reuse any content from New Scientist, either in print or online, please contact the syndication department first for permission. New Scientist does not own rights to photos, but there are a variety of licensing options available for use of articles and graphics we own the copyright to.
Have your say
Only subscribers may leave comments on this article. Please log in.
All comments should respect the New Scientist House Rules. If you think a particular comment breaks these rules then please use the "Report" link in that comment to report it to us.
If you are having a technical problem posting a comment, please contact technical support.
This is very interesting in terms of new understanding of the immune system, in particular the circadian rhythm aspect. In tune with Mick Thacker's 'movement as an antigen' angle, we should be thinking about when we advise patients to exercise in the light of different immune activities at different times of the day.
No comments:
Post a Comment